BSX Chart

1 Month

	Date	Diff	Articles
	2025-05-01	+0.31 %	Boston Scientific (BSX) stock rose by 0.31% following an upgrade from a "hold" to a "buy" rating by StockNews.com, along with multiple price target increases and optimistic performance reports from various analysts, reflecting strong quarterly earnings and positive market sentiment.
Boston Scientific (BSX) stock rose by 0.31% following an upgrade from a "hold" to a "buy" rating by StockNews.com, along with multiple price target increases and optimistic performance reports from various analysts, reflecting strong quarterly earnings and positive market sentiment.
	2025-04-29	+0.55 %	Boston Scientific (BSX) stock rose by 0.55% due to its strong relative strength performance, reaching a 52-week high alongside other stocks like SAP and Howmet Aerospace, suggesting positive market momentum and investor confidence.
Boston Scientific (BSX) stock rose by 0.55% due to its strong relative strength performance, reaching a 52-week high alongside other stocks like SAP and Howmet Aerospace, suggesting positive market momentum and investor confidence.
	2025-04-28	+0.27 %	Boston Scientific (BSX) stock rose 0.27% after Barclays raised its price target for the company from $118.00 to $125.00, highlighting positive sentiment from multiple research firms that have upgraded their ratings and target prices for the stock.
Boston Scientific (BSX) stock rose 0.27% after Barclays raised its price target for the company from $118.00 to $125.00, highlighting positive sentiment from multiple research firms that have upgraded their ratings and target prices for the stock.
	2025-04-24	+2.24 %	Boston Scientific (BSX) stock rose 2.24% after showing strong technical patterns, including a potential double bottom formation and maintaining a high composite rating and impressive industry ranking. The stock's increase is likely attributed to investor confidence in its chart patterns, such as the double bottom, coupled with favorable stock ratings that indicate strong potential for growth.
Boston Scientific (BSX) stock rose 2.24% after showing strong technical patterns, including a potential double bottom formation and maintaining a high composite rating and impressive industry ranking. The stock's increase is likely attributed to investor confidence in its chart patterns, such as the double bottom, coupled with favorable stock ratings that indicate strong potential for growth.
	2025-04-23	+4.07 %	Boston Scientific (BSX) stock rose by 4.07% as part of a broader positive market sentiment toward medical stocks, which were showing high trading volumes and interest, likely driven by ongoing innovations and developments in the healthcare sector.
Boston Scientific (BSX) stock rose by 4.07% as part of a broader positive market sentiment toward medical stocks, which were showing high trading volumes and interest, likely driven by ongoing innovations and developments in the healthcare sector. Boston Scientific's stock rose 4.07% after the company exceeded first-quarter earnings expectations and increased its sales forecast. Boston Scientific (BSX) stock rose by 4.07% as it continues to be favored among hedge funds, as indicated in a recent article highlighting the best stocks under $100 to buy.
	2025-04-21	-1.62 %	Boston Scientific (BSX) stock fell by 1.62% ahead of its upcoming quarterly earnings report, which analysts project may not meet investor expectations given the mixed signals from recent insider selling and market sentiment about company forecasts.
Boston Scientific (BSX) stock fell by 1.62% ahead of its upcoming quarterly earnings report, which analysts project may not meet investor expectations given the mixed signals from recent insider selling and market sentiment about company forecasts.
	2025-04-17	-0.14 %	Boston Scientific (BSX) stock declined by 0.14% as it is currently undergoing a first-stage consolidation phase, making it a stock worth monitoring as it seeks to regain support levels. The decline may be attributed to this consolidation process, which often involves price fluctuations before establishing a stronger upward trend.
Boston Scientific (BSX) stock declined by 0.14% as it is currently undergoing a first-stage consolidation phase, making it a stock worth monitoring as it seeks to regain support levels. The decline may be attributed to this consolidation process, which often involves price fluctuations before establishing a stronger upward trend. Boston Scientific (BSX) stock decreased by 0.14% due to ongoing concerns in the healthcare sector regarding rising costs and potential impacts of tariffs on production and research, particularly related to its reliance on Chinese manufacturing and contract research organizations. Boston Scientific (BSX) stock fell by 0.14% after Needham upgraded the stock to Buy from Hold with a price target of $113, citing better-than-expected results in a recent electrophysiologist survey, which suggested diminished competition risks, indicating that the downgrade likely stirred some investor caution leading to the slight decline.
	2025-04-15	-0.04 %	Boston Scientific (BSX) stock was down 0.04% possibly due to its high valuation metrics, including a forward price-to-sales ratio of 7.2 and a premium price reflecting vulnerability amidst recessionary conditions.
Boston Scientific (BSX) stock was down 0.04% possibly due to its high valuation metrics, including a forward price-to-sales ratio of 7.2 and a premium price reflecting vulnerability amidst recessionary conditions.